Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00491296|
Recruitment Status : Unknown
Verified June 2007 by HaEmek Medical Center, Israel.
Recruitment status was: Not yet recruiting
First Posted : June 26, 2007
Last Update Posted : November 7, 2008
PURPOSE: We determined whether Synergo therapy- intravesical chemotherapy instillation combined with hyperthermia instillation is associated with elevated prostate specific antigen (PSA). MATERIALS AND METHODS: We will treat 25 consecutive patients with bladder cancer with a 6-week course of Synergo therapy, followed by cystoscopy at 6 weeks. Blood samples for PSA determination will obtain before each synergo therapy application and at cystoscopy with each patient also serving as a control.
Evaluating changes in PSA level in patients undergoing treatment with Synergo delivered local hyperthermia combined with intravesical instillation of Mitomycin C for adjuvant treatment or pt. with recurrent tu of bladder post TURT with BCGtreatment.
|Condition or disease||Intervention/treatment|
|Bladder Cancer||Device: SYNERGO Device: SYNERGO-intravesical chemotherapy instillation combined with hyperthermia|
|Study Type :||Observational|
|Study Start Date :||June 2007|
|Estimated Study Completion Date :||June 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00491296
|Contact: doron perez, M.D.||+email@example.com|
|Afula, Israel, 18100|
|Department of urology||Not yet recruiting|
|Afula, Israel, 18101|
|Contact: doron perez, M.D. +972-4-6495115 firstname.lastname@example.org|
|Principal Investigator:||PEREZ DORON, M.D.||HAEMEK MEDICAL CENTER, UROLOGY DEPARTMENT|
|Principal Investigator:||Perez Doron, M.D||haemek medical center|